4031. Adulteration and misbranding of Vio-Ferronate tablets.   U. S. v. Rowell
Laboratories, Inc.   Plea of nolo contendere.   Fine, $350.    (F. D. C. No.
34351.    Sample No. 48581-L.)
INFORMATION FILED: March 19, 1953, District of Minnesota, against Kowell
Laboratories, Inc., Baudette, Minn.
ALLEGED SHIPMENT : On or about February 7,1952, from the State of Minnesota
into the State of North Dakota.
LABEL, IN PAET : (Bottle) "Coated Tablets Vio-Ferronate Ferrous Gluconate
with Liver and Vitamin B-12 * * * Bowell Laboratories Division of
Burbot Liver Products Co.    Baudette, Minnesota."
NATURE OF CHARGE: Adulteration, Section 501 (c), the strength of the article
differed from that which it purported and was represented to possess since
each tablet of the article purported and was represented to contain 3 milli-
grams of thiamine hydrochloride, 1 milligram of pyridoxine, and 30 milligrams
of vitamin C, whereas each tablet contained less than 3 milligrams of thiamine
hydrochloride, less than 1 milligram of pyridoxine, and less than 30 milligrams
of vitamin C
Misbranding, Section 502 (a), the label statements displayed upon the bottles
were false and misleading in that the statements represented and suggested
that each tablet of the article contained 3 milligrams of thiamine hydrochloride,
1 milligram of pyridoxine, and 30 milligrams of vitamin C (ascorbic acid),
whereas each tablet contained less than 3 milligrams of thiamine hydro-
chloride, less than 1 milligram of pyridoxine, and less than 30 milligrams of
vitamin C (ascorbic acid).
DISPOSITION: May 20, 1953. The defendant having entered a plea of nolo
contendere, the court fined it $350.